Chemical Modification of Oligo(Hexamethylene Guanidine): Synthesis of Alkylated Derivatives and Their Estimated Activity Against Mycobacterium Smegmatis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

It was found that oligo(hexamethylene guanidine) (OHMG) reacted very slowly with unactivated high-molecular-mass alkyl halides (dodecyl chloride), possibly due to steric hindrance and the low nucleophilicity of the guanidine moiety. Therefore, this alkyl halide could not be used to modify OHMG under conventional conditions. Ethylation of OHMG was much more facile. However, the substitution in the derivatives was broadly scattered (under ordinary conditions and reagent ratios). It was shown simultaneously that the antibacterial activity of the alkylated derivatives was less than that of the starting OHMG hydrochloride. Benzyl chloride reacted readily with OHMG to produce derivatives with the desired degree of substitution. It was found that benzyl derivatives with 0.2 degree of substitution were more active against mycobacteria than the starting hydrochloride with the activity gradually diminishing if the degree of substitution was increased further. The increased activity may have been related to the optimum increase of OHMG hydrophobicity and/or steric structure. The rather high antibacterial activities of the benzyl derivatives against Mycobacterium smegmatis strain ATCC 607 made them promising for further development and studies of the properties of alkylated OHMG derivatives to discover more active derivatives, including against M. smegmatis. The most obvious candidates could become the methylcarboxy-substituted OHMG derivatives.

About the authors

S. A. Kedik

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Russian Federation, 86 Prosp. Vernadskogo, Moscow, 119571

D. O. Shatalov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Author for correspondence.
Email: shatalov_d@mirea.ru
Russian Federation, 86 Prosp. Vernadskogo, Moscow, 119571

A. D. Askretkov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Russian Federation, 86 Prosp. Vernadskogo, Moscow, 119571

P. M. Isaikina

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Russian Federation, 86 Prosp. Vernadskogo, Moscow, 119571

I. P. Sedishev

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Russian Federation, 86 Prosp. Vernadskogo, Moscow, 119571

A. V. Panov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Russian Federation, 86 Prosp. Vernadskogo, Moscow, 119571

A. S. Evseeva

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Russian Federation, 86 Prosp. Vernadskogo, Moscow, 119571

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Springer Science+Business Media, LLC, part of Springer Nature